Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phase I study of oral mitomycin C.

S T Crooke, M Henderson, M Samson

    Cancer Treatment Reports
    |November 1, 1976
    PubMed
    Summary

    Oral administration of mitomycin C shows unpredictable gastrointestinal absorption. Myelosuppression risk is linked to peak serum levels, suggesting a maximal tolerated dose of 45-50 mg/m2 for this chemotherapy drug.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Transient dilated cardiomyopathy phenotype and positive Bartonella serology in a cat.

    Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2025
    Same author

    Effectiveness of behavioural and psychological interventions for managing obesity in children and adolescents: A systematic review and meta-analysis framed using minimal important difference estimates based on GRADE guidance to inform a clinical practice guideline.

    Pediatric obesity·2025
    Same author

    Association between psychological distress trajectories from adolescence to midlife and mental health during the pandemic: evidence from two British birth cohorts.

    Psychological medicine·2023
    Same author

    Primary care triaging of head and neck cancer referrals using the head and neck cancer risk calculator version 2: impact on a tertiary head and neck service.

    The Journal of laryngology and otology·2022
    Same author

    Developing and testing a case-management intervention to support the return to work of health care workers with common mental health disorders.

    Journal of public health (Oxford, England)·2022
    Same author

    Do initiation rites hasten sexual debut among adolescent girls? A longitudinal analysis from Ghana.

    Culture, health & sexuality·2022

    Area of Science:

    • Oncology
    • Pharmacology
    • Gastroenterology

    Background:

    • Mitomycin C is an antineoplastic agent used in cancer treatment.
    • Understanding its oral bioavailability and toxicity is crucial for effective therapeutic strategies.

    Purpose of the Study:

    • To evaluate the gastrointestinal absorption of oral mitomycin C.
    • To determine the relationship between serum concentrations and myelosuppression.
    • To establish the maximal-tolerated dose (MTD) for oral mitomycin C.

    Main Methods:

    • Pharmacokinetic analysis of oral mitomycin C absorption.
    • Correlation analysis between peak serum concentrations and myelosuppression.
    • Dose-escalation study to determine MTD.

    Main Results:

    • Oral mitomycin C absorption was found to be highly variable.
    • Myelosuppression showed a strong correlation with peak serum concentrations.
    • The probable MTD of oral mitomycin C was determined to be 45-50 mg/m2.

    Conclusions:

    • The variability in oral absorption necessitates careful dosing of mitomycin C.
    • Monitoring peak serum levels is important for managing myelosuppression.
    • The established MTD provides a guideline for safe oral administration of mitomycin C.

    Related Experiment Videos